title: Differentiating pulmonary cavities.
authors.forename: Caroline
authors.initials: C
authors.lastname: O'Connell
authors.forename: Mardiana
authors.initials: M
authors.lastname: Abdul Aziz
authors.forename: John C
authors.initials: JC
authors.lastname: O'Keane
authors.forename: David
authors.initials: D
authors.lastname: Healy
authors.forename: Dermot S
authors.initials: DS
authors.lastname: O'Callaghan
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage; D014408:Biomarkers, Tumor / Q000032:analysis; D001706:Biopsy; D017024:Chemotherapy, Adjuvant; D003520:Cyclophosphamide / Q000008:administration & dosage; D003937:Diagnosis, Differential; D004317:Doxorubicin / Q000008:administration & dosage; D017809:Fatal Outcome; D006801:Humans; D007150:Immunohistochemistry; D008168:Lung / Q000737:chemistry / Q000000981:diagnostic imaging / Q000473:pathology* / Q000601:surgery; D008175:Lung Neoplasms / Q000737:chemistry / Q000175:diagnosis* / Q000628:therapy; D017728:Lymphoma, Large-Cell, Anaplastic / Q000737:chemistry / Q000175:diagnosis* / Q000628:therapy; D008297:Male; D008875:Middle Aged; D011013:Pneumonectomy; D011237:Predictive Value of Tests; D011239:Prednisolone / Q000008:administration & dosage; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome; D014750:Vincristine / Q000008:administration & dosage
chemical_list: D014408:Biomarkers, Tumor; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011239:Prednisolone